Biomedtech 2014 Job Fair
Agreement with the First Medical University
and a full house at the Biomedtech 2014 Job Fair
According to the organizers, at least 200 applicants and 15 employer companies, including the largest players in the Russian and global market of pharmaceuticals, biotechnologies, and R&D in the field of biopharmaceuticals, came to the Hypercube in total. Among those who came to Skolkovo were Bayer, AstraZeneca, Reckitt Benckiser, R-Pharm, KRKA, Pfizer, Invitro and others.
Interestingly, this time Skolkovo residents also presented their vacancies, among them: Selecta Rus, Fusion Pharma, Gemacor Labs, 3D Bioprinting Solutions, etc. The meeting was also attended by headhunting and HR agencies of the Kelly Services level. Representatives of companies not only conducted interviews, but also talked to young people from the stage, telling about how labor relations are built in their companies, how to stand out from hundreds of others in order to get to work with them, what kind of employees they need.
"In the realities of today, namely, the shortage of professional personnel in the labor market, all companies, including such large ones as Reckitt Benckiser, face the task of finding, attracting and developing talented youth. The solution, at first glance, is simple: it is necessary to hold as many events as possible for young people at sites where they could meet and communicate with potential employers. However, there are enough such initiatives, and their effectiveness leaves much to be desired. The organizers from Skolkovo managed to hold a very accurately and qualitatively organized event at the site of the Skolkovo Innovation Center. I am impressed by the idea of combining the topic of innovation and commercialization of startups with a youth, student audience with the participation of large and successful companies. This gives interested young people not only the necessary information, but also sets the right life guidelines, motivates for further development in a modern competitive environment," Yulia Smirnova, Reckitt Benckiser Regional HR Director for Russia and the CIS, commented on the results of work at the Fair.
Graduate student Irina Ryabikina, a graduate of the Moscow Art Institute, found an internship at the Fair for the summer and got acquainted with the HR of large companies: "It was interesting to me, and I have already agreed here with the Biomedical Cluster of the cluster about a summer internship, I learned a lot of useful things about vacancies in R&D "Big Pharma", I will be a graduate student for another 3 years, to study chemistry, but already now I am looking closely, I do not exclude for myself a job in Skolkovo BMT startups." Igor Barinov, a graduate of Moscow State University, is interested in working in the field of bioinformatics. "I want to switch to this area, because it is a very interesting promising topic. And I myself am already developing products for patients, for example, my self-monitoring application for diabetics has become the most popular in the Russian appstore."
The signing of a memorandum of cooperation between the Skolkovo Foundation and the I.M. Sechenov First Moscow State Medical University has become a kind of semantic center of the entire huge event "Biomedtech 2014".
The signing ceremony of the Protocol of Intent (in the photo on the left – Vice-Rector Viktor Fomin)
Kirill Kayem, Vice President, Executive Director of the BMT cluster, said that scientific and innovative projects of the First Medical Center, which are already ready to be converted into startups, including in the form of Small innovative enterprises, can receive the support of the Skolkovo Foundation: both benefits and financial.
"We will regularly hold expert councils together with the University, we will look at projects physically. We will be glad to see the selected teams in Skolkovo as Participants. And for those who are not ready to come to us yet, we will tell you what needs to be done: we will help colleagues prepare a participant's application, a memorandum. So the agreement has a real practical meaning," Kai said at the signing. And a little later in the interview Sk.ru The head of the Biomedical Cluster explained the importance of the Biomedtech 2014 Job Fair for the innovative biomedical community that is being formed around Skolkovo:
"This is our target audience. Not just students come here, but young researchers who are interested in working in R&D in the future. At the Job Fair, as well as at the "Pharma' School", there are young people who have previously passed a certain filter. These are precisely those young professionals who want to work not as medical representatives, but to engage in practical scientific work, to develop new medicines," Kirill Kayem said.
One of the ideas of the Biomedtech 2014 Job Fair was to show the industry that this kind of human resource potential exists in Russia, to demonstrate it to large companies. "Large pharmaceutical companies see that we have young guys who are ready to study and are interested in working in R&D. This is a kind of demonstration of the human resources potential for Big Pharma companies, an impulse that sooner or later will affect the processes of expanding R&D in Russia and in Skolkovo," Kirill Kaem emphasized.
Kamila Zarubina, Senior Analyst of the Biomedical Technologies Cluster, one of the organizers of the Biomedtech Job Fair: "I am very pleased that today the Foundation is signing a cooperation agreement with the University that I graduated from 8 years ago. My "roadmap" to the Skolkovo Foundation was through work at a research institute, a large pharmaceutical company, and I can say that such events for graduates of medical and pharmaceutical universities are an excellent springboard in career terms - at one site you can get a master class from a recruitment agency, then try your hand at the stand a large pharmaceutical company and in a relaxed atmosphere to communicate with a biotech startup and learn how to create your own startup or find a job in a Skolkovo resident."
Indeed, most of the tables and stands displayed in the lobby of the Hypercube, where interviews were conducted, belonged to the companies of "Big Pharma", which bears the brunt of the implementation of long and rather laborious R&D processes for the withdrawal of a new molecule into the final product that appears on the shelves of pharmacies. "We understand that now the main part of potential employers is the industry," Kirill Kayem also said. A startup is at an early stage, and we have the majority of such, it is already an established team, a group of like-minded people. Only startups at a high stage of maturity will look for employees through Job Fairs and recruitment agencies. We expect that with the increase in the volume of research activities, the growth in the number of startups and their maturity, the number of stands of small innovative companies at the Fair will grow."
One of such projects is Selecta (RUS), which presented two vacant positions at the fair. Dmitry Ovchinnikov, Deputy CEO of the company, said Sk.ru that startups today are facing a rather serious personnel crisis, and not all of them are familiar with do not know about us, but we are about them. And the need has already appeared. And the events held by the Skolkovo Foundation help us find each other. Such fairs allow a startup to save money, transfer HR functions outside, and use the potential of outsourcing. All this helps a lot, and we are grateful to the Skolkovo Foundation," said the deputy director of Select (RUS).
Viktor Fomin, Vice-rector for Medical Work at I.M. Sechenov Moscow State Medical University, said that it is a great honor for his university to be one of the first to start cooperation with Skolkovo. The Vice-rector of the "First Medical" stressed that now healthcare and pharmaceuticals are in the focus of the government's attention, and the task of scientific and development institutes is to make these industries self-sufficient. "We need to make sure that we have all the breakthrough technologies here and that they are our own technologies, which is impossible without systematic work on personnel training, without systematic work on scientific research. At the same time, the applied part will be much behind the "First Medical", – Viktor Fomin emphasized.
In an exclusive interview SK.ru The vice-rector identified several areas that, according to him, will be decisive in cooperation with Skolkovo: "Firstly, we are talking about training personnel, not only for innovative applied activities, but also for scientific and practical work. We have created a Center for innovative educational programs "Medicine of the Future", and we will graduate students who will be ready to come, for example, to Skolkovo, to absolutely certain jobs. Secondly, we hope for joint research projects, and as clear and "earthly" as possible: our university now has all the possibilities for preclinical and clinical research. We are talking about cell cultures, and animals, as well as volunteers (healthy volunteers) and patients. We can create a platform for research and testing of medicines that will be prepared and produced here," said Viktor Fomin, Vice–rector for Medical Work at First Medical.
The vice-rector of the "First Medical" also believes that Skolkovo and its university can jointly determine the main directions in biomedicine and biopharma, including creating common startups, small innovative enterprises.
"We can do all this together, and all these directions are reflected in the memorandum of intent that we signed," Viktor Fomin stressed. First of all, we are talking about projects that do not require the formation of an additional regulatory framework, about developments in the field of the introduction of innovative educational technologies, both for students and for practicing doctors. "I think we will reach a level together that will put us above many of the world's leading schools," Viktor Fomin said.
Portal "Eternal youth" http://vechnayamolodost.ru08.07.2014